Table: Immuno Biological Lab -2022/23 group results

Immuno-Biological Laboratories

12/05/2023 07:30

May 12 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          794 mln         647 mln        850 mln                
               (+22.7 pct)     (+7.4 pct)     (+7.0 pct)               
  Operating      58 mln       loss 122 mln      90 mln                 
                                              (+54.2 pct)              
  Recurring   loss 149 mln    loss 243 mln      90 mln                 
  Net
  Net         loss 289 mln    loss 258 mln      80 mln                 
  EPS        loss 31.10 yen  loss 27.78 yen    8.58 yen                
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T